Expression of HVEM has been documented to be increased in ovarian serous adenocarcinoma tissue (17), colorectal cancer epithelium (18), esophageal squamous cell carcinoma (19), and breast cancer (20). This evidence concerns the gene TNFRSF14 and esophageal squamous cell carcinoma.